Working… Menu

Intravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status Epilepticus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03350035
Recruitment Status : Completed
First Posted : November 22, 2017
Last Update Posted : October 22, 2020
Information provided by (Responsible Party):
Marinus Pharmaceuticals

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 18, 2019
Actual Study Completion Date : September 18, 2019
Certification/Extension First Submitted : September 25, 2020